To cite this paper use one of the standards below:
Heterocyclic compounds have important biological activities. Coumarins have pharmacological properties, such as: anti-inflammatories, antibiotics, anticoagulants and are used in medicinal chemistry[1] . Others heterocycles, with Benzimidazoles have antioxidants, anti-inflammatories, antiviral properties[2]. Coumarin-benzimidazole hybrids[3] were synthesized using an ionic liquid (MAI.Cl) as catalyst to obtain compounds with pharmacological properties (30-41% yields). The product were confirmed (m.p, FTIR, NMR 1H and 13C). Antioxidant activity was determined as radical scavenging activity using 2,2-diphenyl-1-picrylhydrazyl (DPPH) method. The absorbance with respect to control is calculated as antioxidant potential, probit regress was applied and EC50 (mol/L) values, due to the non-linear relationship of the method (EC50 15.5±71.5 mol/L and comparative gives literature). Benzothiazole, Benzoxazole, Coumarin–benzimidazole and Coumarin–benzothiazole were screened for their in vitro antibacterial activity against Staphylococcus aureus and Escherichia coli strains by microdilution method CLSI: 125 >2000 mg/mL were observed. In conclusion, were synthesized hybrids and evaluated them for their antibacterial activities and antioxidant potential.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper